News | April 01, 2011

Portable Brain Imaging System can Rapidly Detect Stroke


April 1, 2011 – Jan Medical announced that clinical data related to its portable brain imaging system were disclosed at the Society of Interventional Radiology Annual Meeting. The data demonstrated a breakthrough in detecting strokes.

The system is designed for the diagnosis of traumatic brain injury, including concussions.
Diagnosis utilizing the device takes minutes. It emits no energy into the brain and is therefore positioned as a “Non-Significant Risk” in clinical trial protocols. Continuous monitoring options include hours, days or weeks until the condition is resolved or requires intervention. All other brain imaging alternatives, such as CT and MRI, are snapshots.

Kieran J. Murphy, M.D., vice chair and deputy chief of medical imaging and director of medical imaging research at the University of Toronto presented the data.

“Our study validates that the Jan Medical system represents a new paradigm for detecting, diagnosing and monitoring of stroke,” said Murphy. “The small size, portability and rapidity of imaging will allow diagnosis of stroke victims in minutes, which in turn will allow for stroke triage outside of a hospital setting, thus further reducing the time to initial treatment—which should dramatically improve patient outcomes.”

“Stroke is the third-leading cause of death in the U.S. and the leading cause of disability,” added Paul Lovoi, Ph.D., CEO of Jan Medical. “While some 1.5 million patients present annually with what appear to be stroke symptoms, half of them have actually not had a stroke. We believe that our system can have an enormously favorable impact by empowering healthcare providers to make a reliable assessment of stroke in just minutes. Patient outcomes will then be improved because healthcare providers will have the correct and timely information they need to treat their patients faster, at lower cost and less risk.”

The Jan Medical System is an investigational device in the United States.

For more information: www.janmedical.com


Related Content

News | Cardiovascular Clinical Studies

Nov. 10, 2025 —Genomics, a science-led techbio company, has today announced new research that suggests polygenic risk ...

Home November 12, 2025
Home
News | Cardiovascular Clinical Studies

Oct. 21, 2025 – AskBio Inc., a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG ...

Home October 21, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 25, 2025 — Merck, known as MSD outside of the United States and Canada, has announced that new clinical trial and ...

Home August 25, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 18, 2025 — (Newswise) It’s often mistaken for a heart attack, but Takotsubo cardiomyopathy — previously known as ...

Home August 21, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 20, 2025 — A major international study published in Atherosclerosis* has found that routinely testing for ...

Home August 20, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 4, 2025 — Marea Therapeutics, Inc., a clinical-stage biotechnology company that develops next-generation medicines ...

Home August 04, 2025
Home
News | Cardiovascular Clinical Studies

July 16, 2025 — Medtronic has announced that the first patient has been enrolled in the PEripheral Onyx Liquid Embolic ...

Home July 22, 2025
Home
News | Cardiovascular Clinical Studies

June 11, 2025 — Bayer and the Broad Institute have have extended their research collaboration of 10 years by an ...

Home June 11, 2025
Home
News | Cardiovascular Clinical Studies

May 27, 2025 — Despite scientific advances in cardiovascular care, people in living in rural areas and other communities ...

Home May 27, 2025
Home
News | Cardiovascular Clinical Studies

May 20, 2025 — Shockwave Medical, Inc., part of Johnson & Johnson MedTechhas announced the 30-day primary endpoint ...

Home May 21, 2025
Home
Subscribe Now